down arrow

Hansoh Pharmaceutical Group Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG549581067
HKD
43.00
-0.36 (-0.83%)

Dec 12

HKG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Sino Biopharmaceutical Ltd.
WuXi AppTec Co., Ltd.
China Medical System Holdings Ltd.
Sinopharm Group Co., Ltd.
China Resources Pharmaceutical Group Ltd.
Hygeia Healthcare Holdings Co., Ltd.
Hansoh Pharmaceutical Group Co., Ltd.
Innovent Biologics, Inc.
Akeso, Inc.
HUTCHMED (China) Ltd.
BeiGene Ltd.
Why is Hansoh Pharmaceutical Group Co., Ltd. ?
1
Poor long term growth as Operating profit has grown by an annual rate 10.26% of over the last 5 years
2
With ROE of 15.39%, it has a Very Expensive valuation with a 7.01 Price to Book Value
  • Over the past year, while the stock has generated a return of 131.18%, its profits have risen by 30.8% ; the PEG ratio of the company is 1.5
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Hansoh Pharmaceutical Group Co., Ltd. for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
Hansoh Pharmaceutical Group Co., Ltd.
132.68%
3.28
43.12%
Hang Seng Hong Kong
27.36%
1.03
25.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
9.75%
EBIT Growth (5y)
10.26%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.81
Sales to Capital Employed (avg)
0.40
Tax Ratio
14.03%
Dividend Payout Ratio
42.07%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
59.55%
ROE (avg)
13.25%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
46
Industry P/E
Price to Book Value
7.00
EV to EBIT
44.11
EV to EBITDA
40.04
EV to Capital Employed
33.19
EV to Sales
14.22
PEG Ratio
1.48
Dividend Yield
0.06%
ROCE (Latest)
75.24%
ROE (Latest)
15.39%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Hansoh Pharmaceutical Group Co., Ltd.
Operating Cash Flow
Highest at HKD 9,082.36 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (HKD MM)

Dividend Payout Ratio
Highest at 44.97%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Raw Material Cost
Fallen by -0.37% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hansoh Pharmaceutical Group Co., Ltd.
Operating Profit Margin
Lowest at 25.98 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Non Operating Income
Highest at HKD 0.33 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."